NOVO B — Novo Nordisk A/S Share News
0.000.00%
Last trade - 00:00- DKK1.19tn
- DKK1.28tn
- DKK309.06bn
As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Factbox: Major drugmakers turn to China for licensing deals
Focus: Cherry or tabasco? Perfumers test weight-loss drug users' appetite for food-inspired scents
Lundbeck names former Novo Nordisk CEO Lars Fruergaard Jorgensen as next board chair
China biotech's ingenuity extends to dealmaking
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Eli Lilly's weight-loss pill wins EU drug regulator's backing (updated)
Brief: EMA's CHMP Recommends Extension Of Therapeutic Indication For Pandemic Influenza Vaccine H5N1 AstraZeneca
South Africa revises rules around customisation of weight-loss drugs
Two ships sink near Hormuz after being hit by projectiles amid surge in attacks (updated)
Brief: Walmart Plans To Cover More Than 250 Prescription Drugs Without Charge For Its Employees- Bloomberg News
Factbox: Major drugmakers turn to China for licensing deals
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
Pharma lobby sues Trump administration over Medicare drug price cuts (updated)
Focus: AI companies run virtual drug trials, aim to improve success of human studies
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight
Factbox: Global healthcare companies invest billions to boost US presence
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues
Factbox: Major drugmakers turn to China for licensing deals